Puma Biotechnology and Pierre Fabre’s Amendment of NERLYNX License Agreement

IN BRIEF: McDermott Will & Emery, advised on the matter.McDermott Will & Emery advised Pierre Fabre S.A. with a team including Anne-France Moreau (Life Science &…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Naoual Sadouqi

Author: Naoual Sadouqi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here